Skip to main content

BioServe to Provide Genetic Testing for NGC Medical

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioServe said today that it will provide its genetic testing services for NGC Medical's nutrigenomics testing business.

Under the agreement, BioServe will provide Italy's NGC Medical with its CLIA-certified genomics services, including DNA extraction, QC DNA, and control DNA for the NutriGeneCode testing service.

Beltsville, Md.-based BioServe said that it expects to process around 10,000 NutriGeneCode tests in the next year.

The NutriGeneCode test uses a saliva sample to identify 50 SNPs that are involved in cellular aging and body response, such as lipid and carbohydrate metabolism, hypertension, inflammation, oxidation, and detoxification reactions and DNA repair.

Financial terms of the agreement were not released, but BioServe said that negotiations are ongoing to "develop a more comprehensive partnership between the two companies."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.